Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

BUY
$74.26 - $84.51 $3,341 - $3,802
45 Added 3.49%
1,335 $110,000
Q4 2022

Feb 06, 2023

SELL
$68.3 - $87.44 $11,542 - $14,777
-169 Reduced 11.58%
1,290 $96,000
Q3 2022

Nov 08, 2022

BUY
$82.37 - $107.29 $329 - $429
4 Added 0.27%
1,459 $121,000
Q2 2022

Jul 19, 2022

BUY
$86.5 - $128.27 $14,964 - $22,190
173 Added 13.49%
1,455 $138,000
Q1 2022

Apr 29, 2022

SELL
$101.96 - $128.34 $203 - $256
-2 Reduced 0.16%
1,282 $151,000
Q4 2021

Jan 24, 2022

SELL
$106.37 - $130.68 $850 - $1,045
-8 Reduced 0.62%
1,284 $166,000
Q3 2021

Oct 29, 2021

BUY
$102.91 - $122.75 $1,852 - $2,209
18 Added 1.41%
1,292 $146,000
Q2 2021

Aug 02, 2021

BUY
$83.84 - $104.76 $1,341 - $1,676
16 Added 1.27%
1,274 $132,000
Q1 2021

Apr 29, 2021

BUY
$78.68 - $90.67 $4,563 - $5,258
58 Added 4.83%
1,258 $105,000
Q4 2020

Jan 21, 2021

SELL
$71.69 - $91.23 $4,731 - $6,021
-66 Reduced 5.21%
1,200 $109,000
Q2 2020

Jul 20, 2020

BUY
$57.54 - $76.95 $72,845 - $97,418
1,266 New
1,266 $87,000
Q1 2020

Apr 14, 2020

SELL
$52.41 - $81.0 $524 - $810
-10 Closed
0 $0
Q4 2019

Jan 27, 2020

SELL
$71.7 - $82.09 $143 - $164
-2 Reduced 16.67%
10 $2,000
Q3 2019

Oct 17, 2019

BUY
$61.55 - $75.43 $307 - $377
5 Added 71.43%
12 $3,000
Q2 2019

Jul 23, 2019

SELL
$55.74 - $64.41 $11,148 - $12,882
-200 Reduced 96.62%
7 $1,000
Q1 2019

Apr 11, 2019

SELL
$47.89 - $64.05 $143 - $192
-3 Reduced 1.43%
207 $40,000
Q4 2018

Jan 17, 2019

SELL
$46.41 - $56.94 $36,663 - $44,982
-790 Reduced 79.0%
210 $32,000
Q3 2018

Nov 02, 2018

SELL
$45.7 - $58.03 $1,096 - $1,392
-24 Reduced 2.34%
1,000 $174,000
Q2 2018

Jul 27, 2018

BUY
$42.45 - $51.3 $1,018 - $1,231
24 Added 2.4%
1,024 $149,000
Q2 2017

Aug 10, 2017

BUY
N/A
1,000
1,000 $118,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.